National Biodefense Strategy Act of 2016

wearing an M-17 nuclear, biological, and chemical warfare mask and hood There are many threats from biological weapons including biological terror attacks against the population. The threat is not limited only to terrorism. Dangerous pathogens can be released accidentally from research laboratories and outbreaks of certain infectious diseases can wreak biological havoc. Cases of pathogen releases included the breakout of burkholderia pseudomallei bacterium at Tulane University's National Primate Research Center where many of the lab's primates were infected, as well as a visiting scientist from the US Department of Agriculture. Teams of investigators from the Centers for Disease Control and the Department of Agriculture, along with National Institute of Occupational Safety and Health investigated the matter. The US Army's Dugway Proving Ground in Utah sent live anthrax spores to laboratories in nine states and an army facility in South Korea. Anthrax are very infectious bacteria that infect people by moving through the air. The CDC conducted a thorough investigation and, although no one developed the disease, more than 40 workers at the labs were treated. Examples of disease outbreaks include major international recent events including the Ebola virus, avian influenza and now the Zika virus. The panel concluded that the US biodefense has become too fragmented with authority spread among too many government agencies. They said Congress could repair these flaws by focusing the command and control of biodefense at the White House and empowering one individual with the responsibility and budgetary authority to coordinate the diverse and numerous communities that manage the nation's biodefense. After the panel released its blueprint, Johnson began writing the legislation. According to the Senate report accompanying the bill, "The purpose of S. 2967, the National Biodefense Strategy Act of 2016, is to require the President to develop and execute a comprehensive national biodefense strategy. In 2014, several high-ranking Government officials… convened the Blue Ribbon Study Panel on Biodefense to assess the state of our nation's biodefense capabilities and to recommend improvement measures. S. 2967 codifies key recommendations of this panel by requiring a holistic national strategy that aims to direct and harmonize all existing agency-specific strategies with respect to biodefense." According to Homeland Preparedness News, "Among the report's chief findings was the conclusion that the United States lacks a single federal leader for biodefense, a comprehensive national strategy and a dedicated biodefense budget." The U.S. government spends approximately $6 billion each year on biodefense-specific activities, but the report highlighted the GAO's finding of a fragmentation of biodefense leadership. The GAO said that there are more than two dozen presidentially appointed individuals with biodefense responsibilities and numerous federal agencies with mission responsibilities for supporting biodefense activities. No individual or entity, however, has responsibility for overseeing the nation's biodefense enterprise. == Major provisions ==

The objective of the bill is to improve coordination within the federal government in order to prevent and prepare for a biological attack. For example, the legislation would create a Biodefense Coordination Council which would include representatives from key federal government agencies. If legislation was signed into law, the President of the United States would be required to report to Congress on the status of the biodefense strategy every 180 days until that strategy was fully implemented. • Create, submit, and regularly update a National Biodefense Strategy in order to direct and align efforts by the federal government toward an effective and continuously improving biodefense system. • Create a Biodefense Coordination Council which will provide expertise required to develop the strategy to align various government agencies and their activities into a coordinated biodefense effort. • Report on the total amount of money that federal agencies are spending on bio defense activities annually. The National Biodefense Strategy would serve as a comprehensive guide for U.S. biodefense programs and would include: • A detailed description of every entity and leader responsible for implementing, overseeing, and coordinating federal biodefense activities. • A review of all military and civilian federal government activities regarding biodefense. • A "detailed analyses of recommendations issued by external biodefense review commissions, lessons learned from the government response to public health emergencies within the preceding five years, major biological incident risks, resources and capabilities needed to address identified risks, resource and capability gaps in the biodefense enterprise, and prioritization and allocation of investment across the biodefense enterprise." Other provisions can be viewed on the summary page for the legislation at Congress.gov. == Legislative history ==

On May 23, 2016, Senator Johnson introduced the bill along with Senator Joni Ernst (R-Iowa), who was an original co-sponsor. After introduction: • 5/25/16 - The Senate Committee on Homeland Security and Governmental Affairs considered the bill and ordered it to be reported out of committee favorably, with some amendments. • 8/30/16 - The Senate Committee on Homeland Security and Governmental Affairs again reported a separate version of the bill, along with a committee report (Senate Report 114–306). • 8/30/16 - The bill was placed on the Senate Legislative Calendar number 577. • 9/20/16 – The bill was attached to the Senate's National Defense Authorization Act for Fiscal Year 2017 by Sen. Ernst. == References ==